Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study
Conclusion
Our findings confirm that switching to Duotrav® in PGA monotherapy patients shows IOP-lowering effect with minimal safety concerns.
Funding
Japan Association of Health Service and Alcon Japan. Ltd.
Trial registration
UMIN Clinical Trials Registry identifier, UMIN000007028.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Clinical Trials | Drugs & Pharmacology | Eyes | Glaucoma | Health | Hypertension | Latanoprost | Opthalmology | Study | Timolol | Travatan